Table 2. Primary endpoint – Fatigue (% [n]) (ITT).
| FCM (N = 144) | Placebo (N = 146) | Difference [95% CI] FCM–placebo on Day 56, P-value | |
| ≥1 point decrease in total PFS | 65.3 (94) | 52.7 (77) | 12.5 [1.3, 23.8], P = 0.030 |
PFS Piper fatigue scale.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.